Article

Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease

2024-05-10

Abstract excerpt

<h4>Introduction</h4> The complexity of Inflammatory Bowel Diseases (IBD) presents challenges for the management of these diseases. Predicting treatment outcomes remains difficult, leading to suboptimal outcomes and high costs. Emerging evidence suggests the potential of the gut microbiome in predicting response to biologic treatments. In this prospective study we aimed to predict treatment response to vedolizumab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f14a9c79-5a81-5b10-b6e7-b949e68acfa6
DOI: 10.1101/2024.05.10.24307195

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel diseaseDOI 10.1101/2024.05.10.24307195Read

Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.Semantic proximity Read

Fecal Microbial Community Profiling Allows Discrimination of Phenotype and Treatment Response in Pediatric Crohn's Disease and Ulcerative Colitis-An International Meta-Analysis.Semantic proximity Read

Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn’s DiseaseSemantic proximity Read

Gut microbiome signatures predict 5-ASA efficacy in ulcerative colitisSemantic proximity Read

Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approachSemantic proximity Read

Fecal Microbial and Metabolic Signatures in VEO-IBD: Implications for Unique PathophysiologySemantic proximity Read

Deciphering the microbiome–metabolome landscape of an inflammatory bowel disease inception cohortSemantic proximity Read

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatmentSemantic proximity Read

Diagnosis of Crohn’s disease and ulcerative colitis using the microbiomeSemantic proximity Read

Fecal microbiome of patients with ulcerative colitis reflects their phenotype and inflammatory level.Semantic proximity Read

Multi-omics phenotyping characterizes molecular divergence underlying different clinical scenarios of inflammatory bowel diseaseSemantic proximity Read

A pilot study to identify blood-based markers associated with response to treatment with Vedolizumab in patients with Inflammatory Bowel DiseaseSemantic proximity Read